Stock listing

Danaher Corporation

Selected listing: 0R2B · LSE · USD · GB

Danaher Corporation (LSE:0R2B), Health Technology. Latest release Oct 1, 2026: Julie Sawyer Montgomery Assumes Role as Danaher President and Chief Executive…

0R2B:LSEUSDGBUpdated October 2, 2026

Ticker: LSE:0R2B
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: LSE
Currency: USD

About Danaher Corporation

The company operates in various sectors, focusing on innovation and technology to improve healthcare and life sciences. Danaher is known for its commitment to quality and sustainability, providing essential tools and solutions across multiple industries.

Latest news from Danaher Corporation

Julie Sawyer Montgomery Assumes Role as Danaher President and Chief Executive Officer

October 1, 2026

Leica Biosystems Completes Acquisition of StatLab to Bolster Delivery of More Precise, Timely Diagnostics for Cancer Patients

September 28, 2026

SCIEX Expands BioPhase 8800 System Capabilities to Help Laboratories Accelerate Development and Decision-making for Emerging Therapeutics

September 28, 2026

Danaher Schedules Third Quarter 2026 Earnings Conference Call

September 22, 2026

WHO Grants Emergency Use Listing for Cepheid's Xpert® Hemorrhagic Fever Panel Test to Support Ebola Outbreak Response in the DRC

September 3, 2026

All Danaher Corporation news →

Events

Replays

Danaher Corporation (DHR) Q2 2026 Earnings Call
Tue, Jul 21, 2026 · 08:00 AM ET
Watch
Danaher Corporation (DHR) Q1 2026 Earnings Call
Tue, Apr 21, 2026 · 08:00 AM ET
Watch
Danaher Corporation (DHR) Q4 2025 Earnings Call
Wed, Jan 28, 2026 · 08:00 AM ET
Watch

Research Danaher Corporation

Danaher Corporation company profile

View the public company page for Danaher Corporation on 6ix.

Danaher Corporation news

Read company news and market updates connected to Danaher Corporation.

Danaher Corporation investor events

Find investor webinars, events, and replay context for Danaher Corporation.